Patients' Prognosis of Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-cholangiocarcinoma After Resection

Overview

Journal Cancer Med

Specialty Oncology

Date 2019 Aug 14

PMID 31407490

Citations 20

Authors

Peipei Song

Yutaka Midorikawa

Hisashi Nakayama

Tokio Higaki

Masamichi Moriguchi

Osamu Aramaki

Shintaro Yamazaki

Masaru Aoki

Kenichi Teramoto

Tadatoshi Takayama

Affiliations

Soon will be listed here.

Abstract

Combined hepatocellular-cholangiocarcinoma (cHCC-CC) and intrahepatic cholangiocarcinoma (ICC) are classified into one category, but comparison of prognosis of the two carcinomas remains controversial. The aim of the current study was to investigate surgical outcomes for patients with ICC or cHCC-CC who underwent resection in order to elucidate whether the classification of ICC and cHCC-CC is justified. Subjects were 61 patients with ICC and 29 patients with cHCC-CC who underwent liver resection from 2001 to 2017. Clinic-pathological data from the two groups were compared. Tumor number and vascular invasion were independent risk factors for recurrence-free survival (RFS) in both groups (P < .001 for both). Of note, for patients with ICC, tumor cut-off size of 5 cm showed statistical significance in median RFS (>5 cm vs ≤5 cm, 0.5 years vs 4.0 years, P = .003). For patients with cHCC-CC, tumor cut-off size of 2 cm showed statistical significance in median RFS (>2 cm vs ≤2 cm, 0.6 years vs 2.6 years, P = .038). The median RFS of patients with cHCC-CC was 0.9 years (95% confidence interval: 0.3-1.6), which was poorer than that of patients with ICC (1.3 years, 0.5-2.1) (P = .028); the rate of RFS at 5 years was 0% and 37.7% respectively. Our study supports the concept of classifying ICC and cHCC-CC into different categories because of a significant difference in RFS between the two.

Citing Articles

Evaluation of combined hepatocellular-cholangiocarcinoma using CEUS LI-RADS: correlation with pathological characteristics.

Bao J, Nie Z, Wang Q, Chen Y, Wang K, Liu X Abdom Radiol (NY). 2024; 50(2):646-655.

PMID: 39150545 DOI: 10.1007/s00261-024-04519-x.

Leveraging radiomics and AI for precision diagnosis and prognostication of liver malignancies.

Haghshomar M, Rodrigues D, Kalyan A, Velichko Y, Borhani A Front Oncol. 2024; 14:1362737.

PMID: 38779098 PMC: 11109422. DOI: 10.3389/fonc.2024.1362737.

Update on the Diagnosis and Treatment of Combined Hepatocellular Cholangiocarcinoma.

Chu K, Kawaguchi Y, Wang H, Jiang X, Hasegawa K J Clin Transl Hepatol. 2024; 12(2):210-217.

PMID: 38343605 PMC: 10851068. DOI: 10.14218/JCTH.2023.00189.

Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Chen J, Zhang W, Bao J, Wang K, Zhao Q, Zhu Y Abdom Radiol (NY). 2023; 49(1):93-102.

PMID: 37999743 DOI: 10.1007/s00261-023-04089-4.

Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study.

Zheng C, Gu X, Huang X, Wei Y, Chen L, Luo N Radiol Med. 2023; 128(12):1460-1471.

PMID: 37747668 PMC: 10700214. DOI: 10.1007/s11547-023-01726-2.

References

Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao F . Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology. 2016; 64(4):1178-88. DOI: 10.1002/hep.28744. View

Kim S, Park Y, Lim J, Choi G, Choi J, Kim K . Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2014; 40(8):976-81. DOI: 10.1016/j.ejso.2014.04.016. View

Nathan H, Aloia T, Vauthey J, Abdalla E, Zhu A, Schulick R . A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008; 16(1):14-22. DOI: 10.1245/s10434-008-0180-z. View

Yamazaki S, Takayama T, Kimura Y, Moriguchi M, Higaki T, Nakayama H . Transfusion criteria for fresh frozen plasma in liver resection: a 3 + 3 cohort expansion study. Arch Surg. 2011; 146(11):1293-9. DOI: 10.1001/archsurg.2011.293. View

Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K . Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003; 33(6):283-7. DOI: 10.1093/jjco/hyg056. View

Koh K, Lee H, Choi M, Lee J, Paik S, Yoo B . Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg. 2005; 189(1):120-5. DOI: 10.1016/j.amjsurg.2004.03.018. View

Jan Y, Jeng L, Hwang T, Wang C, Chen M, Chen T . Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology. 1996; 43(9):614-9. View

Kurokawa T, Yamazaki S, Mitsuka Y, Moriguchi M, Sugitani M, Takayama T . Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin. Br J Cancer. 2015; 114(1):53-8. PMC: 4716541. DOI: 10.1038/bjc.2015.423. View

Ng I, Shek T, Nicholls J, Ma L . Combined hepatocellular-cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol. 1998; 13(1):34-40. DOI: 10.1111/j.1440-1746.1998.tb00542.x. View

10.

Liu C, Fan S, Lo C, Ng I, Lam C, Poon R . Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg. 2003; 138(1):86-90. View

11.

Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S . Surgery for small liver cancers. Semin Surg Oncol. 1993; 9(4):298-304. DOI: 10.1002/ssu.2980090404. View

12.

He C, Mao Y, Wang J, Song Y, Huang X, Lin X . The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study. J Gastrointest Surg. 2018; 22(7):1239-1250. DOI: 10.1007/s11605-018-3756-3. View

13.

Lee J, Chung G, Yu S, Hwang S, Kim J, Kim H . Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol. 2010; 45(1):69-75. DOI: 10.1097/MCG.0b013e3181ce5dfa. View

14.

Lin G, Toh C, Wu R, Ko S, Ng S, Chou W . Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. Int J Clin Pract. 2007; 62(8):1199-205. DOI: 10.1111/j.1742-1241.2007.01291.x. View

15.

Chok K, Ng K, Cheung T, Yuen W, Poon R, Lo C . An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma. World J Surg. 2009; 33(9):1916-21. DOI: 10.1007/s00268-009-0112-5. View

16.

Casavilla F, Marsh J, Iwatsuki S, Todo S, Lee R, Madariaga J . Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997; 185(5):429-36. PMC: 2958518. DOI: 10.1016/s1072-7515(97)00088-4. View

17.

Alison M . Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev. 2006; 1(3):253-60. DOI: 10.1385/SCR:1:3:253. View

18.

Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H . Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg. 1999; 6(2):108-16. DOI: 10.1007/s005340050092. View

19.

Jarnagin W, Weber S, Tickoo S, Koea J, Obiekwe S, Fong Y . Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer. 2002; 94(7):2040-6. DOI: 10.1002/cncr.10392. View

20.

Park H, Choi K, Choi S, Choi J, Kim D, Ahn S . Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea. Yonsei Med J. 2011; 52(5):753-60. PMC: 3159948. DOI: 10.3349/ymj.2011.52.5.753. View